October 16 - 19, 2008
Hyatt Regency Huntington Beach
Huntington Beach, CA
At this premier scientific meeting, the world's leading researchers gather to present data and discuss recent directions in oncology research, with a focus on translating the most recent laboratory developments into the development of treatments that improve clinical outcomes for cancer patients. The program, developed under the direction of co-chairs Dennis J. Slamon, MD, PhD, and John Crown, MD, MPH, includes relevant didactic presentations and compelling, interactive discussions.
Faculty are carefully selected from among the researchers at the forefront of the translational work in the topic, whether from academia, government, or industry. The program encourages networking and interaction between the attendees and the renowned faculty members.
Thursday, October 16
12:00 PM - 6:00 PM Registration
6:30 PM - 9:30 PM Welcome Reception
Saturday, October 18
7:00 AM - 8:00 AM Breakfast
8:00 AM - 10:00 AM Session IV: Malignant Angiogenesis and Antiangiogenic Therapies
Chair: George Sledge, MD
10:00 AM - 10:30 AM Break
10:30 AM - 12:30 PM Session V: Malignant Stem Cells as Targets in Oncology
Chair: Hasan Korkaya, DVM, PhD
12:30 - 2:00 PM Lunch
2:00 - 4:00 PM Session VI: Immunotherapies and Vaccine Strategies
Chair: John Glaspy, MD
4:00 PM Afternoon Refreshments
Jointly sponsored by Postgraduate Institute for Medicine and Clinical Care Options, LLC.
In order to receive credit, participants must attend the session and submit a credit application and evaluation form to symposium staff at the end of the program. Certificates will be mailed within 6-8 weeks following the program.